Consolidated Statements of Cash Flows (USD $)	3 Months Ended			12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net loss	$ (1,927,360)	[1]	$ (414,298)	$ (12,583,216)	$ (21,094,983)
Adjustments to reconcile net loss to cash flows from operating activities
Depreciation expense	1,131		1,132	4,526	1,131
Stock based compensation	1,268,307		2,997,503	9,495,292	6,040,144
Issuance of common stock for services	52,000		24,000	1,079,502	751,330
Change in fair value of financial instruments	(271,190)		(8,587,290)	(8,668,688)	5,346,358
Changes in operating assets and liabilities:
Prepaid insurance	(12,203)		17,687	(39,739)	2,968
Other assets					(648)
Amounts on deposit with card processor					90,359
Amounts on deposit with or due from merchant processor	(23,972)		57,815	25,585	(161,686)
Accounts payable and accrued liabilities	(242,529)		1,835,586	2,501	(295,175)
Accrued and deferred personnel compensation	57,675		288,329	(97,074)	226,387
Net cash used in operating activities	(1,073,735)		(3,779,536)	(10,701,833)	(9,099,751)
Cash flows from investing activities
Sale of property and equipment	300			2,505	(9,844)
Net cash provided by (used in) investing activities	300			2,505	(9,844)
Cash flows from financing activities:
Net proceeds from exercise of warrants to purchase common stock			9,000	1,393,973
Issuance of redeemable common and preferred stock and warrants for cash, less issuance costs			4,866,192	4,866,192	13,393,104
Repurchase of common stock					(160,000)
Proceeds from issuance of convertible debt	500,000
Net cash provided by financing activities	500,000		4,875,192	6,260,165	13,233,104
Net (decrease) increase in cash and cash equivalents	(573,435)		1,095,656	(4,439,163)	4,123,509
Cash and cash equivalent at beginning of the period	1,070,748		5,509,911	5,509,911	1,386,402
Cash and cash equivalent at end of the period	497,313	[1]	6,605,567	1,070,748	5,509,911
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	374		374	1,001	5,568
Supplemental statement of cash flows:
Modification and exercise of warrants: Decrease in additional paid-in capital				(287,385)
Modification and exercise of warrants: Increase in additional paid-in capital				287,385
Noncash investing and financing transactions:
Forfeiture of accrued compensation					37,252
Issuance of warrants	118,000
Reclassification of derivative liabilities				$ 8,734,085	$ 481,418

[1] For the three month transition period.